Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCI Group, Inc.HCI · Entity 4402 | Chief Financial Officer | May 08, 2017 | May 10, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCI Group, Inc.
Report date May 08, 2017 · Filed May 10, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-05-08 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2017-05-08 · Tax withholding · Disposed 538 · Balance 0 F2: 538 shares were surrendered to cover the minimum federal income tax liability associated with the vesting of 2,000 restricted shares on May 8, 2017. F3: This Restricted Stock Grant of 30,000 shares effective 5/8/2012 has vested in full. Restrictions on 10,000 shares lapsed in annual increments of 2,000 shares beginning on the first anniversary of the grant date. With respect to the remaining 20,000 restricted shares, the restriction periods lapsed and 4,000 restricted shares vested one year after the market price of HCI common shares equaled or exceeded the target price in each case for 20 consecutive trading days. The target prices set for this grant were $16, $19, $22, $25 and $28. |
| Common stockSEC Table I · non-derivative | Direct | 450 |
Reported balance
Holding disclosure · report date 2017-05-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 450 F1: Shares are held jointly with spouse. |
| Common stockSEC Table I · non-derivative | Direct | 41,571 |
Reported balance
Holding disclosure · report date 2017-05-08 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 41,571 |
| Common stockSEC Table I · non-derivative | Direct | 1,885 |
Reported balance
Holding disclosure · report date 2017-05-08 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,885 F4: Restricted stock grant of 2,500 shares effective 2/28/2014: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of January 15, 2015, January 15, 2016, January 15, 2017, and January 15, 2018. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/28/2014. The number of shares in column 5 includes 625 unvested shares pursuant to this 2/28/2014 restricted stock grant. |
| Common stockSEC Table I · non-derivative | Direct | 1,875 |
Reported balance
Holding disclosure · report date 2017-05-08 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,875 F5: Restricted stock grant of 2,500 shares effective 5/20/2015: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of May 20, 2016, May 20, 2017, May 20, 2018, and May 20, 2019. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/20/2015. The number of shares reported in column 5 represent the remaining unvested shares pursuant to this 5/20/15 restricted stock grant. |
| Common StockSEC Table I · non-derivative | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2017-05-08 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 2,500 F6: Restricted stock grant of 2,500 shares effective 6/06/2016: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of May 20, 2017, May 20, 2018, May 20, 2019, and May 20, 2020. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/06/2016. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are held jointly with spouse.
F2: 538 shares were surrendered to cover the minimum federal income tax liability associated with the vesting of 2,000 restricted shares on May 8, 2017.
F3: This Restricted Stock Grant of 30,000 shares effective 5/8/2012 has vested in full. Restrictions on 10,000 shares lapsed in annual increments of 2,000 shares beginning on the first anniversary of the grant date. With respect to the remaining 20,000 restricted shares, the restriction periods lapsed and 4,000 restricted shares vested one year after the market price of HCI common shares equaled or exceeded the target price in each case for 20 consecutive trading days. The target prices set for this grant were $16, $19, $22, $25 and $28.
F4: Restricted stock grant of 2,500 shares effective 2/28/2014: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of January 15, 2015, January 15, 2016, January 15, 2017, and January 15, 2018. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/28/2014. The number of shares in column 5 includes 625 unvested shares pursuant to this 2/28/2014 restricted stock grant.
F5: Restricted stock grant of 2,500 shares effective 5/20/2015: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of May 20, 2016, May 20, 2017, May 20, 2018, and May 20, 2019. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/20/2015. The number of shares reported in column 5 represent the remaining unvested shares pursuant to this 5/20/15 restricted stock grant.
F6: Restricted stock grant of 2,500 shares effective 6/06/2016: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of May 20, 2017, May 20, 2018, May 20, 2019, and May 20, 2020. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/06/2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2017 Filed May 10, 2017 16:00 UTC | HCI Group, Inc. HCI · Entity 4402 | Tax withholdingCommon stock | 538 | $45.33 | $24,387.54 |
DisclosureSEC source: 0001209191-17-031210 · doc4.xml · nonDerivative · entry 2 Allen Richard R · CIK 0001439141 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · shares: 538 shares were surrendered to cover the minimum federal income tax liability associated with the vesting of 2,000 restricted shares on May 8, 2017. F2 · acquired: 538 shares were surrendered to cover the minimum federal income tax liability associated with the vesting of 2,000 restricted shares on May 8, 2017. F3 · balance_after: This Restricted Stock Grant of 30,000 shares effective 5/8/2012 has vested in full. Restrictions on 10,000 shares lapsed in annual increments of 2,000 shares beginning on the first anniversary of the grant date. With respect to the remaining 20,000 restricted shares, the restriction periods lapsed and 4,000 restricted shares vested one year after the market price of HCI common shares equaled or exceeded the target price in each case for 20 consecutive trading days. The target prices set for this grant were $16, $19, $22, $25 and $28. Read SEC document |
| January 15, 2017 Filed Jan 24, 2017 16:06 UTC | HCI Group, Inc. HCI · Entity 4402 | Tax withholdingCommon stock | 205 | $39.39 | $8,074.95 |
DisclosureSEC source: 0001209191-17-005263 · doc4.xml · nonDerivative · entry 4 Allen Richard R · CIK 0001439141 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,885 F3 · shares: 205 shares were surrendered to cover the minimum federal income tax liability associated with the vesting of 625 restricted shares on 1/15/2017. F3 · acquired: 205 shares were surrendered to cover the minimum federal income tax liability associated with the vesting of 625 restricted shares on 1/15/2017. F4 · balance_after: Restricted stock grant of 2,500 shares effective 2/28/2014: Restriction period will lapse and the restricted shares will vest as follows: 625 shares on each of January 15, 2015, January 15, 2016, January 15, 2017, and January 15, 2018. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/28/2014. The number of shares in column 5 includes 625 unvested shares pursuant to this 2/28/2014 restricted stock grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.